Reply to “Reframing the CHADS-P2A2RC score in chronic coronary syndrome: From ischemic risk stratification to a signal for caution”
- 15 July 2025
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 439, 133615
Abstract
No abstract availableFunding Information
- Società Italiana di Pediatria (JPJ012425)
This publication has 5 references indexed in Scilit:
- Reframing the CHADS-P2A2RC score in chronic coronary syndrome: From ischemic risk stratification to a signal for cautionInternational Journal of Cardiology, 2025
- Risk stratification of net adverse clinical events using CHADS-P2A2RC and CHADS2 scores in chronic coronary syndrome patients without atrial fibrillation: Insights from the CLIDAS-PCIInternational Journal of Cardiology, 2025
- 2024 ESC Guidelines for the management of chronic coronary syndromesEuropean Heart Journal, 2024
- Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudyEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2024
- Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk ScoresJournal of the American Heart Association, 2018